Protective effects of deferiprone and desferrioxamine in brain tissue of aluminum intoxicated mice: An FTIR study

Biomedicine and Preventive Nutrition

Volumn 4, Issue 1, 2014, Pages 53-61

  Sivakumar, Sivaprakasam ^a   Khatiwada, Chandra Prasad ^a   Sivasubramanian, Jeganathan ^a   Raja, Boobalan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Aluminum; Biochemical parameters; DFO and DFP; FTIR

Indexed keywords

EID: 84894044132     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2013.06.001     Document Type: Article

References (48)

1. Tsakiridis P.E. Aluminium salt slag characterization and utilization-A review. J Hazard Mater 2012, 217-8:1-10.
2. Kumar V., Gill K.D. Aluminium neurotoxicity: neurobehavioral and oxidative aspects. Arch Toxicol 2009, 83:965-978.
3. Kawahara M., Kato-Negishi M. Link between aluminum and the pathogenesis of Alzheimer's disease: the integration of the aluminum and amyloid cascade hypotheses. Int J Alzheimers Dis 2011, 276393:1-17.
4. Yokel R.A. Aluminum chelation principles and recent advances. Coord Chem Rev 2002, 228:97-113.
5. Domingo J.L. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents. Alzheimers Dis 2006, 10:331-341.
6. Guo-Ross S., Yang E., Bondy S.C. Elevation of cerebral proteases after systemic administration of aluminum. Neurochem Int 1998, 22:277-282.
7. Ping L., Yu-Na Y., Shi-De W., Huai-Jun D., Guo-Chang F., Xiao-Yan Y. The efficacy of deferiprone on tissues aluminum removal and copper, zinc, manganese level in rabbits. J Inorg Biochem 2005, 99:1733-1737.
8. Ciancioni C., Poignet J.L., Narel C., Delons S., Mauras Y., Allain P., et al. Concomitant removal of aluminium and iron by haemodialysis and haemofiltration after desferrioxamine intravenous infusion. Proc EDTA-ERA 1985, 21:469-473.
9. Fabio G., Minonzio F., Delbini P., Bianchi A., Cappellini M.D. Reversal of cardiac complications by deferiprone and deferoxamine combination therapy in a patient affected by a severe type of juvenile hemochromatosis (JH). Am Soc Hematol 2007, 109:362-364.
10. Ponticelli C., Musallam K.M., Cianciulli P., Cappellini M.D. Renal complications in transfusion-dependent beta thalassaemia. Blood Rev 2010, 24:239-244.
11. Missel J.R., Schetinger M.R., Gioda C.R., Bohrer D.N., Pacholski I.L., Zanatta N., et al. Chelating effect of novel pyrimidines in a model of aluminum intoxication. J Inorg Biochem 2005, 99:1853-1857.
12. Diem M., Griffiths P.R., Chalmers J.M. Vibrational spectroscopy for medical diagnosis 2008, John Wiley and Sons Chichester, UK.
13. Tecott L.H. The genes and brains of mice and men. Am J Psychiatry 2003, 160:646-656.
14. Tubafard S., Fatemi S.J., Saljooghi A.S., Torkzadeh M. Removal of vanadium by combining desferrioxamine and deferiprone chelators in rats. Med Chem Res 2010, 19:854-863.
15. Niehaus W.G., Samuelson B. Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 1968, 6:126-130.
16. Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase (SOD). Indian J Biochem Biophys 1984, 21:130-132.
17. Sinha K.A. Colorimetric assay of catalase. Anal Biochem 1972, 7:389-394.
18. Rotruck J.T., Pop A.L., Ganther H.F., Hafeman B.G., Hoeksira W.G. Selenium: biochemical role as a component of glutathione peroxidise. Science 1973, 179:588-590.
19. Wang L., Mizaikoff B. Application of multivariate data-analysis techniques to biomedical diagnostics based on mid-infrared spectroscopy. Anal Bioanal Chem 2008, 391:1641-1654.
20. Xiaonan L., Molly A.H., Webb, Mariah J.T., Joel P.V.E., Serge I.D., et al. A study of biochemical parameters associated with ovarian atresia and quality of caviar in farmed white sturgeon (Acipenser transmontanus) by Fourier Transform Infrared (FT-IR) Spectroscopy. Aquaculture 2011, 315:298-305.
21. Cakmak G., Togan I., Severcan F. 17β-Estradiol induced compositional, structural and functional changes in rainbow trout liver, revealed by FT-IR spectroscopy: A comparative study with nonylphenol. Aquat Toxicol 2006, 77:53-63.
22. Dogan A., Siyakus G., Severcan F. FTIR spectroscopic characterization of irradiated hazelnut (Corylusavellanal). Food Chem 2006, 100:1106-1114.
23. Guillen M.D., Cabo N. Usefulness of the frequency data of the Fourier transform infrared spectra to evaluate the degree of oxidation of edible oils. J Agric Food Chem 1999, 47:709-719.
24. Toyran N., Zorlu F., Donmez G., Ode K., Severcan F. Chronic hypoperfusion alters the content and structure of proteins and lipids of rat brain homogenates: a Fourier transform infrared spectroscopy study. Eur Biophys J 2004, 33:549-554.
25. Cakmak G., Togan I., Uguz C., Severcan F. FT-IR spectroscopic analysis of rainbow trout liver exposed to nonylphenol. Appl Spectrosc 2003, 57:835-841.
26. Nara M., Okazaki M., Kagi H. Infrared study of human serum very-low-density and low-density lipoproteins. Implication of esterified lipid CO stretching bands for characterizing lipoproteins. Chem Phys Lipids 2002, 117:1-6.
27. Haris P.I., Severcan F. FTIR spectroscopic characterization of protein structure in aqueous and non-aqueous media. J Mol Catal B 1999, 7:207-221.
28. Naumann D., Helm D., Labischinski H. Microbiological characterizations by FT-IR spectroscopy. Nature 1991, 351:81-82.
29. Sivakumar S., Khatiwada C.P., Sivasubramanian J. Bioaccumulations of aluminum and the effects of chelating agents on different organs of Cirrhinus mrigala. Environ Toxicol Pharmacol 2012, 34:791-800.
30. Piga A., Gaglioti C., Fogliacco E., Tricta F. Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis. Haematologica 2003, 88:489-496.
31. Albina M.L., Belles M., Sanchez D.J., Domingo J.L. Evaluation of the protective activity of deferiprone, an aluminum chelator, on aluminum-induced developmental toxicity in mice. Teratology 2000, 62:86-92.
32. Kontoghiorghes G.J. Iron chelation in biochemistry and medicine. Free radicals oxidant stress and drug action 1987, 277-303. Richelieu Press, London. C. Rice-Evans (Ed.).
33. Ringborn A. Complexation in analytical chemistry 1963, Interscience (Wiley), New York, NY.
34. Kontoghiorghes G.J. Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs. Toxicol Lett 1995, 80:1-18.
35. Anderson M.E., Meister A. Inhibition of gamma-glutamyl transpeptidase and in-duction of glutathionuria by gamma-glutamyl amino acids. Proc Natl Acad Sci U S A 1986, 14:5029-5032.
36. Shrivastava S., Abdulla M. Combined effect of HEDTA and Selenium against aluminum induced oxidative stress in rat brain. J Trace Elem Med Biol 2011, 26:1-38.
37. Yin H., Xu L., Porter N.A. Free radical lipid peroxidation: mechanisms and analysis. Chem Rev 2011, 111:5944-5972.
38. Lamba O.P., Lal S., Yappert M.C., Borchman D. Spectroscopic detection of lipid peroxidation products and structural changes in a sphingomyelin model system. Biochim Biophys Acta 1991, 1081:181-187.
39. Takahashi H., French S.M., Wong P.T.T. Alterations in hepatic lipids and proteins by chronic ethanol intake: a high-pressure Fourier Transform Infrared spectroscopic study on alcoholic liver disease in the rat alcohol. Clin Exp Res 1991, 15:219-223.
40. Liu K., Bose R., Mantsch H.H. Infrared spectroscopic study of diabetic platelats. Vib Spectrosc 2002, 28:131-136.
41. Rebai O., Djebli N.E. Chronic exposure to aluminum chloride in mice: exploratory behaviors and spatial learning. Adv Biol Res 2008, 2:26-33.
42. Jackson M., Mantsch H.H. The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit Rev Biochem Mol Biol 1995, 30:95-120.
43. Sebnem G., Bozoglu F., Severcan F. Differentiation of mesophilic and hermophilic bacteria with Fourier Transform Infrared Spectroscopy. Appl Spectrosc 2007, 61:186-192.
44. Kontoghiorghes G.J., Eracleous E., Economides C., Kolnagou A. Advances in iron overload therapies. Prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NAll and their combinations. Curr Med Chem 2013, 19:2663-2681.
45. Suramana T., Sindhuphak R., Dusitsin N., Posayanonda T., Sinhaseni P. Shift in FTIR spectrum patterns in methomyl - Exposed rat spleen cells. Sci Total Environ 2001, 270:103-108.
46. Wolkers W.F., Looper S.A., McKiernan A.E., Tsvetkova N.M., Tablin F., Crowe J.H. Membrane and protein properties of freeze-dried mouse platelets. Mol Membr Biol 2002, 19:201-210.
47. Evans W.H., Hardison W.G. Phospholipid, cholesterol, poly-peptide and glycoprotein composition of hepatic endosome subfractions. Biochem J 1985, 15:33-36.
48. Eybla V., Kotyzova D., Kolek M., Koutensky J., Nielsen P. The influence of deferiprone (L1) and deferoxamine on iron and essential element tissue level and parameters of oxidative status in dietary iron-loaded mice. Toxicol Lett 2002, 128:169-175.